Behavioral: Administration of probiotic (L. rhamnosus and L. acidophilus) ( DrugBank: Acidophilus )
1 disease
| ID | Disease name (Link within this page) | Number of trials |
|---|---|---|
| 97 | Ulcerative colitis | 1 |
97. Ulcerative colitis
Clinical trials : 2,527 / Drugs : 1,465 - (DrugBank : 259) / Drug target genes : 144 - Drug target pathways : 202
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT00374725 (ClinicalTrials.gov) | February 2003 | 7/9/2006 | Treatment of Ulcerative Colitis With a Combination of Lactobacillus Rhamnosus and Lactobacillus Acidophilus. | Treatment of Ulcerative Colitis With a Combination of Lactobacillus Rhamnosus and Lactobacillus Acidophilus. A Randomised Placebo Controlled Trial | Ulcerative Colitis | Behavioral: Administration of probiotic (L. rhamnosus and L. acidophilus) | Odense University Hospital | University of Southern Denmark;Crohn's and Colitis Foundation | Completed | 18 Years | N/A | Both | 130 | N/A | Denmark |